SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following a blowout second-quarter earnings report, characterized by massive revenue growth and significantly raised full-year guidance that has silenced many skeptics. Community sentiment is overwhelmingly bullish, with investors aggressively debating the stock's potential to sustain this momentum toward new highs and celebrating the company's strong positioning within the expanding AI software infrastructure.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently driving significant community speculation as investors position themselves ahead of the upcoming earnings report, with many closely watching for potential updates on the company's AI-powered smart glasses and broader turnaround efforts. Market participants are debating the stock's valuation as a potential long-term play, while sentiment remains divided between bullish sentiment regarding user engagement and revenue growth against skepticism regarding management's leadership and the company's long-term profitability.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to an unexpected $1.4 billion convertible debt exchange for equity, which has sparked intense debate over the balance between long-term financial health and short-term share dilution. The community remains deeply divided, with some investors viewing the move as a strategic cleanup of the balance sheet ahead of potential acquisition activity, while others are frustrated by the downward price pressure and the ongoing lack of clarity regarding management's broader acquisition strategy.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant investor buzz following an expanded global footprint with new drug approvals in the UAE, while the community remains hyper-focused on upcoming earnings and potential partnership news. Investors are actively debating whether these developments and the companys recent activity indicate a turning point for the stock amidst heavy short interest.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is trending as investors react to a significant earnings beat, raised revenue guidance, and the acquisition of Astrobotic Technology, which secures the firm a pivotal role in government lunar initiatives. While some community members express frustration over recent price volatility and disconnects from broader space sector momentum, others are actively accumulating shares, citing a massive backlog and critical partnerships that position the company as a key infrastructure player in the evolving space economy.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is trending following the announcement of a five-year, multi-exabyte storage agreement with CoreWeave valued at hundreds of millions of dollars. The community is actively debating the stock's potential as an AI infrastructure player, with many discussing the impact on revenue guidance and debating whether the recent price rally warrants a potential future share offering.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors eagerly anticipate a potential breakthrough announcement regarding the 80th event in the company's REGAL Phase 3 study. The community is actively debating the timing of this data release, with intense discussion surrounding ongoing M&A speculation, options market activity, and the divide between optimistic long-term bulls and skeptical short-sellers.

Sterling Infrastructure, Inc. engages in the provision of construction solutions. It operates through the following segments: Transportation Solutions, E-Infrastructure Solutions, and Building Solutions. The Transportation Solutions segment provides infrastructure and rehabilitation services for highways, roads, bridges, airports, ports, light rail systems, water and wastewater facilities, and storm drainage systems. The E-Infrastructure Solutions segment develops advanced, large-scale site development systems and services for data centers, e-commerce distribution centers, warehousing facilities, transportation projects, energy infrastructure, and other specialized developments. The Building Solutions segment provides residential and commercial concrete foundation services for single-family and multi-family homes, as well as parking structures, elevated slabs, and other concrete construction projects. The company was founded in 1955 and is headquartered in The Woodlands, TX.

Sterling Infrastructure Inc

Sterling Construction Company, Inc.

Sterling Construction Company is generating intense investor conversation as the stock navigates a volatile period characterized by record-breaking quarterly growth and strong data center demand set against broader market pressure. The community is actively debating the stock's valuation, with many bullish investors viewing recent pullbacks as compelling buying opportunities, while others analyze how long-term AI infrastructure tailwinds and backlog visibility will sustain its upward trajectory.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is attracting significant investor attention driven by the strategic hiring of a former Mossad Director to lead its defense division and a substantial institutional stake from BlackRock. The community remains hyper-focused on the company's autonomous drone technology and its potential role in upcoming defense contracts, with many actively debating whether this institutional backing and high short interest will catalyze a significant short squeeze leading into the upcoming earnings report.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as investors focus on recent pipeline updates and the long-term commercial potential of Casgevy, while the community remains divided over management's performance and the stock's stagnant price action. Market sentiment is heavily influenced by expectations for upcoming clinical trial readouts and ongoing speculation regarding potential M&A activity within the gene-editing sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
